The Utilisation Of Thermal Methods For The Screening Of Three Component Co-amorphous Systems
Indomethacin and piroxicam are known to become amorphous upon rapid cooling after melting. Multiple three-component co-amorphous mixtures have been produced via a melt quench method to evaluate the influence of the third component on stability and physical properties on the co-amorphous mixture of p...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
University of Huddersfield Press,
2018-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_e22f267f0df24a4e93618d639a2c4ebc | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Alessandra D'Angelo |e author |
| 700 | 1 | 0 | |a Benjamin Edgar |e author |
| 700 | 1 | 0 | |a Milan Antonijevic |e author |
| 245 | 0 | 0 | |a The Utilisation Of Thermal Methods For The Screening Of Three Component Co-amorphous Systems |
| 260 | |b University of Huddersfield Press, |c 2018-07-01T00:00:00Z. | ||
| 500 | |a 10.5920/bjpharm.2017.21 | ||
| 500 | |a 2058-8356 | ||
| 520 | |a Indomethacin and piroxicam are known to become amorphous upon rapid cooling after melting. Multiple three-component co-amorphous mixtures have been produced via a melt quench method to evaluate the influence of the third component on stability and physical properties on the co-amorphous mixture of piroxicam and indomethacin. These have then been tested using thermal gravimetric analysis, differential scan calorimetry and hot stage microscopy. Results have confirmed the creation of a three-component co-amorphous system. | ||
| 546 | |a EN | ||
| 690 | |a tga | ||
| 690 | |a dsc | ||
| 690 | |a co-amorphous | ||
| 690 | |a hsm | ||
| 690 | |a Pharmacy and materia medica | ||
| 690 | |a RS1-441 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n British Journal of Pharmacy, Vol 2, Iss 2 (2018) | |
| 787 | 0 | |n https://www.bjpharm.org.uk/article/id/50/ | |
| 787 | 0 | |n https://doaj.org/toc/2058-8356 | |
| 856 | 4 | 1 | |u https://doaj.org/article/e22f267f0df24a4e93618d639a2c4ebc |z Connect to this object online. |